PSA decrease after levofloxacin therapy in patients with histological prostatitis

Archivio Italiano di Urologia e Andrologia

Volumn 76, Issue 4, 2004, Pages 154-158

  Guercio, Stefano ^a   Terrone, Carlo ^a,b   Tarabuzzi, Roberto ^a   Poggio, Massimiliano ^a   Cracco, Cecilia ^a   Bollito, Enrico ^b   Scarpa, Roberto Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Antibiotics; Biopsy; Levofloxacin; Prostate; Prostate specific antigen; Prostatitis

Indexed keywords

LEVOFLOXACIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INCIDENCE; CHRONIC PROSTATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; DRUG EFFECT; HUMAN; MALE; OUTPATIENT; PROSTATE BIOPSY; PROSTATE CARCINOMA; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

AGED; ANTI-BACTERIAL AGENTS; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATITIS; RETROSPECTIVE STUDIES;

EID: 12344335485     PISSN: 11243562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mettlin C, Jones GW, Avarette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: Prostate and endometrial cancer. Cancer 1993; 43:42
2. AUA: American Urological Association policy statement: early detection of prostate cancer and use of transrectal ultrasound. Baltimore: 1991
3. Catalona WJ, Richie JP, Ahman FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994; 151:1283
4. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum PSA values. J Urol 1994, 151:1571
5. Brawer MK. Prostate specific antigen: current Status. CA: a Cancer Journal for Clinicians 1999; 49:264
6. Gion M. Il PSA: parametro chiave nel trattamento del cancro prostatico. In Intramed, Il carcinoma della prostata. Diagnosi. Milano: 2000:34
7. Brawer MK. Prostate Specific Antigen. New York: Marcel Dekker Inc., 2001
8. Punglia RS, D'Amico AV, Catalona WJ, Rohel KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2003; 349:335
9. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated PSA serum prostate-specific antigen. J Urol; 154:407
10. Lorente JA, Arabgo O, Bielsa R, Cortadellas, Gelabert-Mas A. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Intern J Biol Markers 2002; 17:84
11. Potts JM. Prospective identification of national institutes of health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164:1550
12. Ascoli R, Galuffo A, Lupo A, Di Gregorio L, Allegro R, Serretta V, Messina G, Pavone Macaluso M. Modificazioni del PSA dopo terapia antibiotica in pazienti candidati alla biopsia prostatica. 77° Congresso Nazionale Società Italiana di Urologia: Poster C151; abstract book pg.118
13. Schaeffer AJ, Wu S-C, Tennenberg AM, Zadeikis N. Levofloxacin and ciprofloxacin in the treatment of chornic bacterial prostatitis lower serum prostate specific antigen. J Urol 2004; 171(4 Suppl):62 Abs No 237
14. Langtry HD and Lamb HM. Levofloxacin. Its use in infection of the respiratory tract, skin, soft tissue and urinary tract. Drugs 1998; 56:487
15. Bundrick W, Heron SP, Ray P et al. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urol 2003; 62:537